Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

590 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Safety and efficacy of oral octreotide in acromegaly: results of a multicenter phase III trial.
Melmed S, Popovic V, Bidlingmaier M, Mercado M, van der Lely AJ, Biermasz N, Bolanowski M, Coculescu M, Schopohl J, Racz K, Glaser B, Goth M, Greenman Y, Trainer P, Mezosi E, Shimon I, Giustina A, Korbonits M, Bronstein MD, Kleinberg D, Teichman S, Gliko-Kabir I, Mamluk R, Haviv A, Strasburger C. Melmed S, et al. Among authors: mercado m. J Clin Endocrinol Metab. 2015 Apr;100(4):1699-708. doi: 10.1210/jc.2014-4113. Epub 2015 Feb 9. J Clin Endocrinol Metab. 2015. PMID: 25664604 Clinical Trial.
Effect of growth hormone administration frequency on 24-hour growth hormone profiles and levels of other growth related parameters in girls with Turner's syndrome. Dutch Working Group on Growth Hormone.
van Teunenbroek A, de Muinck Keizer-Schrama SM, Stijnen T, Mouton JW, Blum WF, Mercado M, Baumann G, Drop SL. van Teunenbroek A, et al. Among authors: mercado m. Clin Endocrinol (Oxf). 1993 Jul;39(1):77-84. doi: 10.1111/j.1365-2265.1993.tb01754.x. Clin Endocrinol (Oxf). 1993. PMID: 7688672
Biochemical evaluation of disease activity after pituitary surgery in acromegaly: a critical analysis of patients who spontaneously change disease status.
Espinosa-de-Los-Monteros AL, Sosa E, Cheng S, Ochoa R, Sandoval C, Guinto G, Mendoza V, Hernández I, Molina M, Mercado M. Espinosa-de-Los-Monteros AL, et al. Among authors: mercado m. Clin Endocrinol (Oxf). 2006 Mar;64(3):245-9. doi: 10.1111/j.1365-2265.2006.02430.x. Clin Endocrinol (Oxf). 2006. PMID: 16487431
A prospective, multicentre study to investigate the efficacy, safety and tolerability of octreotide LAR (long-acting repeatable octreotide) in the primary therapy of patients with acromegaly.
Mercado M, Borges F, Bouterfa H, Chang TC, Chervin A, Farrall AJ, Patocs A, Petersenn S, Podoba J, Safari M, Wardlaw J; SMS995B2401 Study Group. Mercado M, et al. Clin Endocrinol (Oxf). 2007 Jun;66(6):859-68. doi: 10.1111/j.1365-2265.2007.02825.x. Epub 2007 Apr 25. Clin Endocrinol (Oxf). 2007. PMID: 17465997 Free PMC article. Clinical Trial.
Surgical reintervention in acromegaly: is it still worth trying?
Espinosa de los Monteros AL, González B, Vargas G, Sosa E, Guinto G, Mercado M. Espinosa de los Monteros AL, et al. Among authors: mercado m. Endocr Pract. 2009 Jul-Aug;15(5):431-7. doi: 10.4158/EP09066.ORR. Endocr Pract. 2009. PMID: 19491070
Management of acromegaly in Latin America: expert panel recommendations.
Barkan A, Bronstein MD, Bruno OD, Cob A, Espinosa-de-los-Monteros AL, Gadelha MR, Garavito G, Guitelman M, Mangupli R, Mercado M, Portocarrero L, Sheppard M. Barkan A, et al. Among authors: mercado m. Pituitary. 2010 Jun;13(2):168-75. doi: 10.1007/s11102-009-0206-y. Pituitary. 2010. PMID: 19882249 Free PMC article. Review.
Efficacy and safety of radiotherapy in acromegaly.
González B, Vargas G, Espinosa-de-los-Monteros AL, Sosa E, Mercado M. González B, et al. Among authors: mercado m. Arch Med Res. 2011 Jan;42(1):48-52. doi: 10.1016/j.arcmed.2011.01.004. Arch Med Res. 2011. PMID: 21376263
590 results